Screening for colorectal cancer with faecal occult blood test is effective

Colorectal cancer is a major cause of death in the Western world. Towler et al (p 559) conducted a systematic review of trials of screening for colorectal cancer with the faecal occult blood test, Hemoccult. Meta-analysis of results from the four randomised controlled trials showed that screening reduced mortality from colorectal cancer by 16% for those allocated to screening and by 23% for those who were actually screened. A biennial Hemoccult screening programme offered to 10 000 people aged >= 40 years, of whom about two thirds attended for at least one test, would prevent 8.5 deaths from colorectal cancer over 10 years. The authors conclude that more information is needed about the harmful effects of screening, the community's responses, and costs before widespread screening can be recommended.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult
Bernie Towler, Les Irwig, Paul Glasziou, Jan Kewenter, David Weller, and Chris Silagy
BMJ 1998 317: 559-565. [Abstract] [Full Text] [PDF]




Access all current jobs at BMJ Group
Whats new online at Student 

BMJ
Listen to the latest 

BMJ Interview